Moderna (MRNA) Tops Q3 EPS by 195c
Tweet
Share
E-mail
Get Alerts MRNA Hot Sheet
Join SI Premium – FREE
Moderna (NASDAQ: MRNA) reported Q3 EPS of $0.03, $1.95 better than the analyst estimate of ($1.92). Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.24 billion.
For earnings history and earnings-related data on Moderna (MRNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SpaceX tumbles amid AI spending concerns; Musk outlines $1 trillion revenue target
- UroGen Pharma (URGN) Tops Q2 EPS by 2c
- Acacia Research (ACTG) Tops Q2 EPS by 22c
Create E-mail Alert Related Categories
Earnings, Hot EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
